| Product Code: ETC6186128 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The neurology market in Australia is experiencing significant growth due to the rising incidence of neurological disorders, along with advancements in diagnostics, treatments, and therapies. The market is influenced by the increasing demand for neurological care across various sub-specialties, including stroke management, epilepsy, and neurodegenerative diseases. The expanding healthcare infrastructure and the growing number of specialized neurology centers across Australia are expected to further boost the market.
Australias neurology market is driven by the growing prevalence of neurological diseases and disorders, such as dementia, stroke, and migraine. The increasing number of neurological clinical trials and the rise in neurological research are contributing to the market`s development. Moreover, advances in treatment options, including personalized medicine and biologics, are expected to support market expansion. Despite this, high treatment costs and limited access to specialized care in rural areas present ongoing challenges.
The broader Australia Neurology Market is challenged by increasing healthcare costs, shortage of neurologists, and the complexity of diagnosing and treating neurological conditions. Slow adoption of new technologies in smaller healthcare settings also hinders market growth.
The broader neurology market in Australia encompasses diagnostics, therapeutics, and monitoring technologies, offering a diverse range of investment options. This sector benefits from ongoing innovation, increased healthcare expenditure, and an aging population. Venture capital in neurology-focused startups, investments in private specialty clinics, and funding public-private research projects are some of the viable investment paths.
Overall, Australia`s neurology market benefits from the Medicare Benefits Schedule (MBS), which subsidizes neurology consultations, diagnostic services, and treatments. The government also promotes clinical research through grants from the NHMRC to support innovations in neurology.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Neurology Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Neurology Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Neurology Market - Industry Life Cycle |
3.4 Australia Neurology Market - Porter's Five Forces |
3.5 Australia Neurology Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Neurology Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.7 Australia Neurology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Australia Neurology Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Australia Neurology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Australia |
4.2.2 Technological advancements in neurology diagnostics and treatment |
4.2.3 Growing awareness about neurological conditions among the population |
4.3 Market Restraints |
4.3.1 Limited access to specialized neurology care in remote areas of Australia |
4.3.2 High cost of neurology treatments and medications |
4.3.3 Shortage of skilled neurologists in the country |
5 Australia Neurology Market Trends |
6 Australia Neurology Market, By Types |
6.1 Australia Neurology Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Neurology Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Neurology Market Revenues & Volume, By Neurodegenerative Diseases, 2021- 2031F |
6.1.4 Australia Neurology Market Revenues & Volume, By Neurovascular Diseases, 2021- 2031F |
6.1.5 Australia Neurology Market Revenues & Volume, By Neuro-infectious Diseases, 2021- 2031F |
6.1.6 Australia Neurology Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Neurology Market, By Procedure |
6.2.1 Overview and Analysis |
6.2.2 Australia Neurology Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.2.3 Australia Neurology Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.2.4 Australia Neurology Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F |
6.2.5 Australia Neurology Market Revenues & Volume, By Alzheimer's Disease, 2021- 2031F |
6.2.6 Australia Neurology Market Revenues & Volume, By Stroke, 2021- 2031F |
6.2.7 Australia Neurology Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Neurology Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Australia Neurology Market Revenues & Volume, By Adult, 2021- 2031F |
6.3.3 Australia Neurology Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4 Australia Neurology Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Australia Neurology Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Australia Neurology Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Australia Neurology Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.4.5 Australia Neurology Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.4.6 Australia Neurology Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Neurology Market Import-Export Trade Statistics |
7.1 Australia Neurology Market Export to Major Countries |
7.2 Australia Neurology Market Imports from Major Countries |
8 Australia Neurology Market Key Performance Indicators |
8.1 Average wait time for neurology appointments |
8.2 Patient satisfaction with neurology services |
8.3 Number of clinical trials for neurological treatments in Australia |
9 Australia Neurology Market - Opportunity Assessment |
9.1 Australia Neurology Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Neurology Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.3 Australia Neurology Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Australia Neurology Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Australia Neurology Market - Competitive Landscape |
10.1 Australia Neurology Market Revenue Share, By Companies, 2024 |
10.2 Australia Neurology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here